Coherus Announces BLA Filing for Lucentis® (ranibizumab) Biosimilar Candidate Accepted by FDA for Review
Go back to Coherus Announces BLA Filing for Lucentis® (ranibizumab) Biosimilar Candidate Accepted by FDA for Review| Charming Shoppes (NASDAQ: CHRS) | Delayed: 2.02 -0.16 (7.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.18 | 52 Week High | $31.98 | |||
| Open | $2.19 | 52 Week Low | $12.04 | |||
| Day High | $2.21 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $-0.10 | |||
| Volume | 879,713 | |||||
